Brand family
All Cefask registrations
Cefask is registered with DRAP 6 registrations, carrying this name and its variants. The price index lists a single manufacturer for the group.
- Registrations
- 6
- Manufacturers
- 1
- Dosage forms
- Capsule · Suspension
- Approved price range
- Rs 293.68 – Rs 526.25
Registrations
| Registered name | Reg. No. | Strength | Form | Manufacturer | Price from |
|---|---|---|---|---|---|
| Cefask 200mg Capsule | 121565 | 200mg | Capsule | Citi pharma ltd | Rs 378.59 |
| Cefask 400Mg Capsule | 035202 | 400Mg | Capsule | Citi pharma ltd | Rs 526.25 |
| Cefask Capsule 200 mg | 013141-EX | 200 mg | Capsule | — | — |
| Cefask Capsule 400 mg | 014000-EX | 400 mg | Capsule | — | — |
| Cefask DS 200mg/5mL Suspension | 121566 | 200mg/5mL | Suspension | Citi pharma ltd | Rs 349.47 |
| Cefask Suspension | 035203 | — | Suspension | Citi pharma ltd | Rs 293.68 |
How these are grouped
These registrations are grouped by the words in their registered name. Strength, pack size, dosage form and trailing variant words such as Forte, Extra, CF, DS and XR are removed before grouping, so Panadol Tablet, Panadol CF Tablet and Panadol Extra Tablet count as one group. Names that only share a first word but mean different things — for example two companies' unrelated products — can still land together; the registered name of every row is shown so the grouping is checkable.
Source: the bundled DRAP registered-products index and the DRAP price index. Prices are regulatory listings, not pharmacy stock or a retail quote.